Workflow
Humon Share(002237)
icon
Search documents
恒邦股份(002237) - 关于对外投资设立子公司的公告
2025-06-27 09:15
| 证券代码:002237 | 证券简称:恒邦股份 | 公告编号:2025-048 | | --- | --- | --- | | 债券代码:127086 | 债券简称:恒邦转债 | | 交易方:烟台综合保税区华晟发展有限公司 成立时间:1991 年 11 月 20 日 山东恒邦冶炼股份有限公司 关于对外投资设立子公司的公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 一、对外投资概述 1.公司拟与烟台综合保税区华晟发展有限公司(以下简称"华晟发展")签署 《烟台恒邦综保国际供应链有限公司合资合作协议书》,拟共同出资设立烟台恒邦 综保国际供应链有限公司(以下简称"恒邦综保")(拟定名,以登记机关最终核 准为准),注册资本为人民币1,000万元。其中,公司出资800万元人民币,占注册 资本的80%,华晟发展出资200万元人民币,占注册资本的20%。 2.根据《深圳证券交易所股票上市规则》《公司章程》《子公司管理制度》, 本次对外投资事项已经公司第九届董事会2025年第二次临时会议审议通过,无需提 交公司股东大会审议。 3.公司本次拟以自有资金 800 万元与 ...
恒邦股份(002237) - 关于召开2025年第三次临时股东大会的通知
2025-06-27 09:15
| 证券代码:002237 | 证券简称:恒邦股份 | 公告编号:2025-051 | | --- | --- | --- | | 债券代码:127086 | 债券简称:恒邦转债 | | 本公司及董事会全体成员保证信息披露内容的真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 根据《中华人民共和国公司法》《深圳证券交易所股票上市规则》和《公司章 程》的规定,山东恒邦冶炼股份有限公司(以下简称"公司")基于公司第九届董 事会 2025 年第二次临时会议审议事项,定于 2025 年 7 月 16 日召开 2025 年第三次 临时股东大会,会议对董事会需要提交公司股东大会审议的议案进行审议,有关具 体事项如下: 一、召开会议基本情况 1.股东大会届次:2025 年第三次临时股东大会 2.会议召集人:山东恒邦冶炼股份有限公司董事会 3.会议召开的合法、合规性:本次股东大会会议召开符合有关法律、行政法规、 部门规章、规范性文件和《公司章程》的相关规定。 4.现场会议召开时间:2025年7月16日下午14:30 网络投票时间:2025年7月16日。其中: 山东恒邦冶炼股份有限公司 关于召开 2025 年第三次临时 ...
恒邦股份(002237) - 第九届监事会2025年第二次临时会议决议公告
2025-06-27 09:15
| 证券代码:002237 | 证券简称:恒邦股份 | 公告编号:2025-046 | | --- | --- | --- | | 债券代码:127086 | 债券简称:恒邦转债 | | 山东恒邦冶炼股份有限公司 第九届监事会 2025 年第二次临时会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 2.审议通过《关于调整公司与江西铜业及其关联方 2025 年日常关联交易预计金 额的议案》 关联监事姜伟民先生回避表决。 一、监事会会议召开情况 山东恒邦冶炼股份有限公司(以下简称"公司")于 2025 年 6 月 20 日以电子 邮件等方式向全体监事发出了《关于召开第九届监事会 2025 年第二次临时会议的通 知》,会议于 2025 年 6 月 27 日上午以现场与通讯相结合的方式召开。会议应出席 监事 3 人,实际出席监事 3 人(其中,以通讯表决方式出席会议的监事有吴忠良先 生、姜伟民先生)。会议由监事会主席吴忠良先生召集并主持,本次会议的召集、 召开和表决程序符合《公司法》《公司章程》的有关规定。 二、监事会会议审议情况 经与会监事认真审议,通过 ...
恒邦股份(002237) - 第九届董事会2025年第二次临时会议决议公告
2025-06-27 09:15
| 证券代码:002237 | 证券简称:恒邦股份 | 公告编号:2025-045 | | --- | --- | --- | | 债券代码:127086 | 债券简称:恒邦转债 | | 山东恒邦冶炼股份有限公司 第九届董事会 2025 年第二次临时会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整,没有虚假记 载、误导性陈述或重大遗漏。 一、董事会会议召开情况 经与会董事认真审议,通过如下议案: 1.审议通过《关于聘任公司 2025 年度审计机构的议案》 本议案已经公司第九届董事会审计委员会审议通过。 表决结果:9 票同意,0 票反对,0 票弃权。本议案尚需提交公司 2025 年第三次 临时股东大会审议。 同意聘任安永华明会计师事务所(特殊普通合伙)为公司 2025 年度审计机构。 《关于聘任公司 2025 年度审计机构的公告》(公告编号:2025-047)详见 2025 年 6 月 28 日《证券时报》《中国证券报》《上海证券报》《证券日报》和巨潮资讯 网(http://www.cninfo.com.cn)。 2.审议通过《关于对外投资设立子公司的议案》 山东恒邦冶炼股份有限公司(以下 ...
恒邦股份:拟发行不超过20亿元中期票据及超短期融资券
news flash· 2025-06-27 09:13
恒邦股份(002237)公告,为优化债务结构,降低财务风险,满足生产经营需求,公司拟向中国银行间 市场交易商协会申请注册发行新一期中期票据及超短期融资券。其中,中期票据发行规模不超过20亿 元,期限不超过5年;超短期融资券发行规模亦不超过20亿元,期限最长不超过270天。募集资金将用于 偿还银行贷款、补充流动资金及其他合规用途。该议案已通过董事会审议,尚需股东大会批准及中国银 行间市场交易商协会批准注册。 ...
恒邦股份:拟投资设立控股子公司
news flash· 2025-06-27 09:12
Group 1 - The company plans to establish Yantai Hengbang Comprehensive Bonded International Supply Chain Co., Ltd. in collaboration with Huasheng Development, with a registered capital of 10 million yuan [1] - The company will contribute 8 million yuan, accounting for 80% of the registered capital [1] - The investment aims to leverage each party's strengths, improve resource utilization efficiency, optimize resource allocation, and enhance the security and stability of the company's raw material supply [1]
金属锌概念下跌0.92%,7股主力资金净流出超3000万元
Group 1 - The metal zinc sector experienced a decline of 0.92%, ranking among the top losers in the concept sector, with companies like Hengbang Co., Hunan Gold, and Pengxin Resources showing significant drops [1] - Among the concept sectors, digital currency led with a gain of 4.72%, while metal zinc was one of the few sectors that declined [1] - Major outflows of capital from the metal zinc sector totaled 644 million yuan, with 27 stocks experiencing net outflows, and Zijin Mining leading with a net outflow of 168 million yuan [1][2] Group 2 - The top gainers in the metal zinc sector included ST Shengtun, West Mining, and Wolong New Energy, with respective increases of 2.39%, 0.97%, and 0.51% [1] - The stocks with the highest net outflows included Hunan Gold, Hengbang Co., and Xingye Silver Tin, with net outflows of 146 million yuan, 77 million yuan, and 73 million yuan respectively [1][2] - The trading volume for the top losers in the metal zinc sector showed significant turnover rates, with Hengbang Co. at 7.37% and Hunan Gold at 4.90% [2]
大涨超40%!谁开到了“黄金盲盒”?
Core Viewpoint - The recent rise in gold prices is driven by multiple factors, including geopolitical tensions, expectations of interest rate cuts in the U.S., and increased demand for gold from central banks, leading to significant gains in gold stocks and related funds [1][6][7]. Group 1: Gold Price Movement - The COMEX gold price has recovered to $3,400 per ounce, with a 3.22% increase over three days as of June 13 [1]. - Gold ETFs have seen an average increase of over 27% this year, with some reaching as high as 43% [1][3]. - The net subscription of gold ETFs has exceeded 10.5 billion shares this year, bringing the total scale to 72.93 billion yuan [1]. Group 2: Fund Performance - Several actively managed funds, which do not explicitly focus on gold, have benefited significantly from the rise in gold prices, with some reporting gains exceeding 40% this year [1][3]. - The Ping An Xinli Mixed A fund added five gold stocks to its top ten holdings in Q1, contributing to its rapid net value increase [3]. - The Huafu Yongxin Flexible Allocation Mixed A fund has a significant portion of its assets (nearly 80%) in gold stocks, achieving a 40.8% increase this year [3][5]. Group 3: Investment Insights - Analysts suggest that the recent rise in gold prices is influenced by a combination of easing international trade tensions and lower-than-expected U.S. inflation data, which has bolstered expectations for Federal Reserve interest rate cuts [6]. - Central banks are showing strong demand for gold to maintain a stable monetary system, with the European Central Bank projecting gold to account for 20% of global reserves by 2024, surpassing the euro [6]. - The investment value of gold stocks is being reassessed, with many companies reporting net profit growth exceeding expectations, indicating a favorable outlook for future performance [6][7].
6月13日晚间重要公告一览
Xi Niu Cai Jing· 2025-06-13 10:43
Group 1 - Company GuoDeWei plans to repurchase shares with a total investment of between 100 million to 150 million yuan, with a maximum repurchase price of 53 yuan per share, expecting to buy back between 1.89 million to 2.83 million shares, accounting for 0.78% to 1.17% of total share capital [1] - Company Shuangliang Energy has won a bid for the Gansu Energy Chemical Qinyang 2×660MW coal power project, with a total bid amount of 237 million yuan, representing 1.82% of the company's projected revenue for 2024 [1] - Company China Pacific Insurance reported a total premium income of 227.17 billion yuan from its two subsidiaries in the first five months, with a year-on-year growth of 10.2% for its life insurance subsidiary and 0.5% for its property insurance subsidiary [1][2] Group 2 - Company LuKang Pharmaceutical has received a drug registration certificate for injectable Cefoperazone Sodium, a third-generation cephalosporin with broad-spectrum antibacterial properties [3] - Company 吉祥航空 reported a 4.97% year-on-year increase in passenger turnover in May, with a seat occupancy rate of 86.14%, up 3.70% year-on-year [4][5] - Company DuRui Pharmaceutical's subsidiary has also received a drug registration certificate for injectable Cefoperazone Sodium [6] Group 3 - Company KeLan Software announced that part of the shares held by its controlling shareholder will be auctioned, involving 5.09 million shares, accounting for 1.07% of the total share capital [7] - Company HuaCan Optoelectronics received a government subsidy of 87.84 million yuan, which is expected to positively impact the company's pre-tax profit for 2025 [8] - Company JinZhi Technology has won a bid for projects from the State Grid and China Resources New Energy, with a total bid amount of 84.41 million yuan [9] Group 4 - Company Vision China completed a capital increase for its subsidiary, raising 100 million yuan to accelerate its layout in the AI field [11] - Company Youa Co. received a profit distribution of 96.03 million yuan from its investment in Changsha Bank [13] - Company WanBangde's subsidiary obtained a patent for a deuterated compound, enhancing the chemical stability and reducing toxicity [16] Group 5 - Company DongCheng Pharmaceutical completed the enrollment of all 488 participants in the Phase III clinical trial for Fluorine-18 PSMA peptide injection, aimed at prostate cancer diagnosis [17] - Company China Merchants Expressway announced that its first phase of medium-term notes for 2024 will pay interest on July 2, 2025, with a total issuance of 2.5 billion yuan and an interest rate of 2.35% [18] - Company JinPu Titanium's subsidiary has temporarily suspended production for maintenance due to falling product prices and high production costs [20] Group 6 - Company BeiLu Pharmaceutical received a marketing authorization for Iodinated Contrast Injection in Hungary, marking another approval in the EU [22] - Company LiXing Co. obtained an overseas investment certificate for its wholly-owned subsidiary in Singapore, with a total investment of 2.16 million yuan [24] - Company LangKun Technology won a garbage collection service project with a bid amount of 21.57 million yuan [26] Group 7 - Company KeRui International plans to transfer 55% of its subsidiary Tianjin ZhiRui's equity for 41.96 million yuan [28] - Company Nanjing JuLong intends to invest 130 million yuan to build a production project for special materials with an annual output of 40,000 tons [30] - Company NanShan Intelligent plans to use up to 50 million yuan of idle funds for cash management in safe and liquid financial products [32] Group 8 - Company GuangLian Aviation completed the business change registration for its subsidiary, involving the introduction of strategic investors [34] - Company XiaoFang Pharmaceutical signed a cooperation agreement to develop a new drug for hair loss treatment [36] - Company GuiZhou SanLi plans to sign a 150 million yuan technology transfer and development contract with Guangdong Pharmaceutical University [38] Group 9 - Company ST SiLong's subsidiary received a drug registration certificate for Famotidine injection, used for treating upper gastrointestinal bleeding [52] - Company ZhongKe Information's executive plans to reduce holdings of up to 180,000 shares, accounting for 0.06% of total share capital [53] - Company KeLun Pharmaceutical's injectable Cefoperazone Sodium/Chloride Sodium injection received drug registration approval [54] Group 10 - Company LuXin Investment plans to transfer 10.06% of its stake in LuXin HuiJin for 203 million yuan, aiming to focus on its main business [56] - Company Western Gold plans to acquire 100% of Xinjiang MeiSheng for 1.655 billion yuan [58] - Company JinTou City Development intends to swap assets worth 5.862 billion yuan, changing its main business to urban centralized heating [60]
黄金概念延续强势 恒邦股份2连板
news flash· 2025-06-13 01:35
智通财经6月13日电,黄金概念延续昨日强势,恒邦股份走出2连板,西部黄金、萃华珠宝涨停,晓程科 技、曼卡龙、赤峰黄金、四川黄金等跟涨。消息面上,国际金价早盘涨逾1%,逼近3430美元/盎司。 黄金概念延续强势 恒邦股份2连板 ...